Published in Gene Therapy Weekly, November 24th, 1997
I. Drexler, representing colleagues from the Institute for Molecular Virology, the Technical University of Dresden, and the Johannes Gutenberg-University, Germany, presented results at the 3rd European Conference on Gene Therapy of Cancer, held September 11-13, 1997, in Berlin, Germany, suggesting that the modified vaccinia virus Ankara (MVA) might have a successful future as a cancer immunotherapeutic.
"The modified vaccinia virus Ankara, a highly attenuated vaccinia...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.